To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer's Disease
Conditions: Ensure the Legality and Compliance of the Testing Process Interventions: Drug: Jiedu Yizhi Formula; Drug: Donepezil Hydrochloride Tablets Sponsors: Changchun University of Chinese Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
A Single Dose Escalation Study of HHT201 in Healthy Subjects
Conditions: Alzheimer Disease Interventions: Drug: Donepezil Dihydroxynaphthalate for Injection Sponsors: Shanghai Synergy Pharmaceutical Sciences Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)
Conditions: Alzheimer ' s Disease Interventions: Drug: MK-1167; Drug: Donepezil; Drug: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept ®) in Healthy Male Volunteers
Conditions: Alzheimer Disease Interventions: Drug: GB-5001A; Drug: GB-5001D; Drug: Oral cohort Sponsors: G2GBio, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Condition: Osteoporosis Interventions: Drug: Donepezil; Drug: Placebo Sponsors: Duke University; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
Condition: Mild Alzheimer Disease Interventions: Drug: PM012; Drug: PM012 Placebo; Drug: Donepezil; Drug: Donepezil placebo Sponsors: Mediforum Ltd., Co.; LSK Global Pharma Services Co. Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2023 Category: Research Source Type: clinical trials
